A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.

Mason, Barbara J, Crean, Rebecca, Goodell, Vivian, Light, John M, Quello, Susan, Shadan, Farhad, Buffkins, Kimberly, Kyle, Mark +3 more·2012·Neuropsychopharmacology
DOI 10.1038/npp.2012.14

Cited by (241)

Items 101–200 of 241

  1. Addiction and Sleep Disorders
    Jonathan Ek, William S. Jacobs, Brett Daniel Kaylor, William Vaughn McCall · 2021 · Advances in experimental medicine and biology
  2. Pharmacotherapies for cannabis use disorder
    Francesca Spiga, Thomas Parkhouse, Victor M. Tang, Jelena Savović, Bernard Le Foll, Suzanne Nielsen · 2025 · Cochrane Database of Systematic Reviews
  3. Guanfacine attenuates adverse effects of dronabinol (THC) on working memory in adolescent-onset heavy cannabis users: A pilot study
    Mathai, David S., Holst, Manuela, Rodgman, Christopher, Haile, Colin N., Keller, Jake, Hussain, Mariyah Z., Kosten, Thomas R., Newton, Thomas F., Verrico, Christopher D. · 2018 · The Journal of Neuropsychiatry and Clinical Neurosciences
  4. Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders
    Bradford S. Martins, Will Rutland, João Paulo De Aquino, Benjamin Kazer, Melissa Christine Funaro, Marc Nicholas Potenza, Gustavo A. Angarita · 2022 · Current Addiction Reports
  5. Dosing and Monitoring: Children and Adolescents.
    Glenn S. Hirsch · 2018 · Europe PMC (PubMed Central)
  6. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice
    Matthew L. Eckard, Steven G. Kinsey · 2021 · Neuropharmacology
  7. Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
    Benedikt B. Claus, Michael Specka, Heath B. McAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet · 2020 · Frontiers in Psychiatry
  8. ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework
    Udi E. Ghitza · 2014 · Frontiers in Psychiatry
  9. Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs
    B. Levi Bolin, Joseph L. Alcorn, Anna R. Reynolds, Joshua A. Lile, William Walton Stoops, Craig R. Rush · 2016 · Current topics in behavioral neurosciences
  10. Prevalence and Treatment of Substance Misuse in Older Adults: Beyond Early Adulthood
    Jiahao Hu, Neha Kulkarni, Peter Maliha, George Thomas Grossberg · 2024 · Substance Abuse and Rehabilitation
  11. Gabapentin — The Popular but Controversial Anticonvulsant Drug May Be Zeroing in on the Pathophysiology of Disease
    Michael Raymond Binder · 2021 · American Journal of Clinical and Experimental Medicine
  12. Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study
    Anees Bahji, Yu Li, Rachel Vickers‐Smith, Stephen Crystal, Robert D. Kerns, Kirsha S. Gordon, Alexandria Macmadu, Melissa Skanderson, Kaku So‐Armah, Minhee Sung et al. · 2022 · International Journal of Environmental Research and Public Health
  13. Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
    Udo Bonnet, Heath B. McAnally, Norbert Scherbaum · 2021 · Drugs
  14. Management of withdrawal from alcohol and other drugs
    Nicholas Lintzeris, Sandra Sunjic, Apo Demirkol, Mira Branezac, Nadine Ezard, Krista J. Siefried, Liam S. Acheson, Florence Bascombe, Chris Tremonti, Paul Haber · 2019
  15. Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology
    Julia Sinclair, Nicola J. Kalk, Stephen John Kaar, Roberta Agabio, Shalini Arunogiri, Adam M. Bisaga, Edward Chesney, Chris Daly, Jonathan Dewhurst, Tom P. Freeman et al. · 2026 · Journal of Psychopharmacology
  16. Gabapentin for the Treatment of Substance Use Disorders
    Robert H. Howland · 2013 · Journal of Psychosocial Nursing and Mental Health Services
  17. Identifying strengths in youths at substance use treatment admission
    Maria E. Pagano, Nadia M. Raj, Christine Rhodes, Amy R. Krentzman, Michelle Little · 2019 · The American Journal of Drug and Alcohol Abuse
  18. A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.
    Rachel Little, Dale A. D’Mello · 2022 · PubMed Central
  19. Psychiatric Uses of Gabapentin.
    Jon C Martin, Danielle M. Gainer · 2022 · PubMed Central
  20. Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action
    Myra Alayoubi, Brittany A. Henry, Catherine M. Cahill, Ziva D. Cooper · 2024 · Drugs
  21. Post–acute Withdrawal Syndrome
    Casey A. Grover, Drew Sturgill, Lee Goldman · 2022 · Journal of Addiction Medicine
  22. Novel Pharmacotherapeutic Interventions for Cannabis Use Disorder
    Brittany L. Mason, Alaa Mustafa, Francesca Mapua Filbey, E. Sherwood Brown · 2016 · Current Addiction Reports
  23. Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users.
    Joshua A. Lile, Joseph L. Alcorn, Lon R. Hays, Thomas H. Kelly, William Walton Stoops, Michael J. Wesley, Philip M. Westgate · 2021 · Experimental and Clinical Psychopharmacology
  24. Behavioral Interventions and Pharmacotherapies for Cannabis Use Disorder
    Aaron J. Bobb, Kevin P. Hill · 2014 · Current Treatment Options in Psychiatry
  25. Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating
    Tyler R. Chesney, Laura Matsos, Jennifer L. Couturier, Natasha Johnson · 2013 · International Journal of Eating Disorders
  26. A Qualitative Examination of Gabapentin Misuse Inside of Treatment and Recovery Settings
    Mance E. Buttram, Steven P. Kurtz · 2020 · Journal of Studies on Alcohol and Drugs
  27. Sleep and Substance-Use Disorder
    Aniruddha Basu, Naveen Anand, Mrinmay Das · 2022 · Springer eBooks
  28. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.
    Michael J. Wesley, Philip M. Westgate, William Walton Stoops, Thomas H. Kelly, Lon R. Hays, Joshua A. Lile · 2018 · Experimental and Clinical Psychopharmacology
  29. A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence
    Evgeny M. Krupitsky, Рыбакова Ксения Валерьевна, Скурат Евгения Петровна, Natalia V. Semenova, Н. Г. Незнанов · 2020 · S S Korsakov Journal of Neurology and Psychiatry
  30. Considerations for Anesthesia in Older Adults with Cannabis Use
    Elena Ahrens, Luca J. Wachtendorf, Kevin P. Hill, Maximilian Sebastian Schaefer · 2024 · Drugs & Aging
  31. Cannabinoid Hyperemesis Syndrome (CHS) - An emerging gastrointestinal disorder and clinical challenge
    Robin B. McFee · 2024 · Disease-a-Month
  32. Attenuation of cannabis withdrawal symptoms by Prosopis farcta extract, its luteolin and melatonin in mice: Involvement of brain‐derived neurotrophic factor and dopamine
    Javad Ghasemian Yadegari, Ahmad Adineh, Hamidreza Mohammadi, S Davari, Yousef Veisani, Hori Ghaneialvar, Ali Aidy, Naser Abbasi, Elahe Karimi · 2024 · Cell Biochemistry and Function
  33. Pharmacotherapy for Adolescents with Substance Use Disorders
    Darren Courtney, Robert Milin · 2015 · Current Treatment Options in Psychiatry
  34. The Treatment of Cannabis Use Disorder
    Itai Danovitch, David A. Gorelick · 2018 · Elsevier eBooks
  35. Electroacupuncture prevents cocaine-induced conditioned place preference reinstatement and attenuates ΔFosB and GluR2 expression
    Ai T. M. Nguyen, Tran Van Bao Quach, Peddanna Kotha, Szu-Yu Chien, Iona J. MacDonald, Hsien‐Yuan Lane, Cheng‐Hao Tu, Jaung‐Geng Lin, Yi‐Hung Chen · 2021 · Scientific Reports
  36. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care
    Tauheed Zaman, Dawn M. Bravata, Amy L. Byers, Erin E. Krebs, Samuel J. Leonard, Friedhelm Sandbrink, Wylie Barker, Salomeh Keyhani · 2023 · BMC Psychiatry
  37. Treatment of Cannabis Use Disorders
    Divya Ramesh, Margaret Haney · 2014 · Springer eBooks
  38. Addiction and Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management
    David Hudson, Nisha Howarth, Francisco Javier Idalsoaga, Yi Nong Song, Alvi Husni Islam, Saranya Theiventhiran, Luis Antonio Díaz, Juan Pablo Arab · 2024 · Current Hepatology Reports
  39. Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana
    Timmen L. Cermak · 2016 · Journal of Psychoactive Drugs
  40. Epileptic Spikes in EEG and Migraine Attacks in the Course of Cannabis Withdrawal: A Case Report
    Kristina Adorjan, Agnieszka I. Chrobok, Gabi Koller, Susanne Karch, Oliver Michael Pogarell · 2019 · Clinical EEG and Neuroscience
  41. Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
    Valentina F. Kitchigina · 2021 · Neuroscience and Behavioral Physiology
  42. Pharmacological Treatment of Substance Abuse Disorders
    Wilfrid N. Raby, John J. Mariani, FRANCES RUDNICK LEVIN, Edward V. Nunes · 2015 · Wiley eBooks
  43. Beyond abstinence: Redefining success in cannabis use disorder treatment
    Tobias Atkin, FRANCES RUDNICK LEVIN, JOHN MARIANI, Christina Brezing · 2026 · Addiction
  44. The Cannabis-Psychosis Spectrum: Clinical Manifestations, Conversion Risk, and Therapeutic Strategies
    Valerio Ricci · 2025 · Clinical Neuropsychopharmacology and Addiction
  45. Emerging pharmacological strategies for the treatment of cannabis use disorder
    Anees Bahji · 2025 · Expert Opinion on Pharmacotherapy
  46. Characterization of an Amphetamine Interference from Gabapentin in an LC–HRMS Method
    Ana Celia Muñoz-Muñoz, Teresa M. Pekol, Dana Schubring, Robin Hyland, Charlene Johnson, Lawrence J. Andrade · 2019 · Journal of Analytical Toxicology
  47. Treatment Strategies for Cannabis Use in Schizophrenia
    Brian Schultz, Lisette Rodriguez-Cabezas, Dan Angres, Matthew J. Smith · 2015 · Current Treatment Options in Psychiatry
  48. Cannabis Withdrawal
    Nicolas J. Schlienz, Ryan G. Vandrey · 2018 · Springer eBooks
  49. Diagnosis and Classification
    2019 · American Psychiatric Association Publishing eBooks
  50. Tobacco, cannabis, and the liver
    Kinza Tareen, Gerald Scott Winder · 2024 · Clinical Liver Disease
  51. Effects of repeated cue exposure on cannabis craving
    Jessica S. Fogel, Thomas H. Kelly, Arit M. Harvanko, Joshua A. Lile · 2015 · Drug and Alcohol Dependence
  52. Off-label medications for addictive disorders
    Tyler S. Vanderhoof · 2023 · Current Psychiatry
  53. Insomnia in Patients With Substance Use Disorders: Assessment and Management
    Cris Hanacek, Julian Lane, Yi‐lang Tang · 2025 · Journal of Psychiatric Practice
  54. Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?
    Patrycja Kleczkowska, Irena Smaga, Małgorzata Filip, Magdalena Bujalska‐Zadrożny · 2016 · Neurotoxicity Research
  55. La protection des enfants et des adolescents contre les risques du vapotage
    Nicholas Chadi, Ellie Vyver, Richard E. Bélanger · 2021 · Paediatrics & Child Health
  56. Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification: Two Subtypes?
    Benedikt Bernd Claus, Norbert Scherbaum, Michael Specka, Patrik Roser, Udo Bonnet · 2023 · Journal of Psychoactive Drugs
  57. Pharmacological management of psychoactive substance withdrawal syndrome
    Dimy Fluyau, Sarah Cook, Ashmeer Chima, Vasanth Kattalai Kailasam, Neelambika Revadigar · 2021 · Drugs & Therapy Perspectives
  58. Substance Use
    Caroline R. McKinnon, Deborah Johnson, Linda M. Stephan · 2021 · Wiley eBooks
  59. The impacts of cannabis on adolescent psychological development
    Timmen L. Cermak, Mark Stanford · 2022 · Elsevier eBooks
  60. Adolescent Cannabis Use Disorder
    Leslie H. Lundahl, David M. Ledgerwood · 2025 · Springer eBooks
  61. Unraveling the Enigma of Cannabinoid Hyperemesis Syndrome: A Narrative Review of Diagnosis and Management
    Shemyia A Smith, Mayar A Safwat, Brian J. Piper, Maame A Addison · 2025 · Cureus
  62. Urinary Δ9-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review
    Danielle McCartney, Chris Irwin, Jonathon Carl Arnold, Rebecca Gordon, Andrew J. McLachlan, Iain S. McGregor · 2026 · Pharmacological Research
  63. Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications—a systematic review
    Valerio Ricci, Thomas Fraccalini, Giovanni Martinotti, Giuseppe Maina · 2026 · American Journal on Addictions
  64. The Role of γ-Aminobutyric Acid in the Interoceptive Effects of Oral Δ9-Tetrahydrocannabinol in Humans
    Joshua A. Lile, Jessica S. Fogel, Thomas H. Kelly · 2017 · Elsevier eBooks
  65. Pregabalin reduces smoking and drinking in alcohol dependent subjects
    Evgeny M. Krupitsky, Рыбакова Ксения Валерьевна, Скурат Евгения Петровна, A. Mikhailov, Н. Г. Незнанов · 2019 · European Neuropsychopharmacology
  66. Cannabis Use in Adolescents
    Lily Rabinow, Emily Dries, Neal D. Hoffman · 2025 · Pediatrics in Review
  67. Acute Management of Substance-Related and Addictive Disorders: A Review
    Elizabeth A. Foote, Charles H. Dukes · 2017 · Psychiatric Annals
  68. Anticonvulsants to Treat Cannabis Use Disorder
    Barbara J. Mason · 2018 · Springer eBooks
  69. From Bud to Brain: A Psychiatrist's View of Marijuana
    Timmen L. Cermak · 2020 · Cambridge University Press eBooks
  70. Should You Recommend Cannabinoids for This Patient With Painful Neuropathy?
    Gerald W. Smetana, Jeanette M. Tetrault, Kevin P. Hill, Risa Beth Burns · 2021 · Annals of Internal Medicine
  71. HOSPITAL DE SAÚDE MENTAL PROFESSOR FROTA PINTO: PATRIMÔNIO DA SAÚDE MENTAL TERCIÁRIA NO CEARÁ
    Yzy Maria Rabelo Câmara · 2022 · Amplla Editora eBooks
  72. A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials
    Eric G. Smith, Hannah L. Grigorian · 2023 · Journal of Clinical Psychopharmacology
  73. Comparative effectiveness of gabapentin and pregabalin on reduction in alcohol use: A nationwide observational cohort study
    Tommy Gunawan, Joshua C. Gray, Mingjian Shi, Thomas S. Wingo, Aliza P. Wingo, David A. Fiellin, John Tazare, Mehdi Farokhnia, Lorenzo Leggio, Henry R. Kranzler et al. · 2026 · medRxiv
  74. Strategies for Prevention or Treatment of Tobacco and Cannabis Use Disorder.
    Katherine N. DeJong, Beth A. Choby, Amy Miyoshi Valent · 2022 · PubMed
  75. Recent Advances in Drug Development
    Frank J. Vocci · 2014 · Springer eBooks
  76. Medications for the Treatment of Addiction – A Neurobiological Perspective
    George F. Koob, Michael A. Arends, Michel Le Moal · 2014 · Elsevier eBooks
  77. Substance Abuse: Cannabis‐Related Disorders
    Benjamin R. Nordstrom, Sarah C. Akerman, FRANCES RUDNICK LEVIN · 2015
  78. Gabapentin for Cannabis Dependence
    Peter Roy‐Byrne · 2012 · Journal watch
  79. Patient abusing alcohol or drugs? Help starts with a single question.
    Daniel C. Vinson · 2013 · PubMed
  80. Pharmacotherapies for Cannabis Use Disorders
    Aimee L. McRae‐Clark · 2017 · Elsevier eBooks
  81. Cannabis-Entzug in der EEG-Praxis – ein Fallbeispiel
    Agnieszka I. Chrobok, Kristina Adorjan · 2017 · Das Neurophysiologie-Labor
  82. Cannabis Use Disorders in Primary Care: Screening and Treatment Suggestions
    Suzanne Turner, Maya Nader, Lisa E. Graves · 2017 · Medical Research Archives
  83. Innovative pharmakologische Ansätze zur Behandlung von Suchterkrankungen
    Tomislav Majić, Stefan Gutwinski, Christian Alfons Müller, Nikola Schoofs, Andreas Heinz · 2018 · Elsevier eBooks
  84. Medications for Substance Use and Relapse Prevention
    Christopher Joseph Hammond, Pravesh Sharma · 2019 · Springer eBooks
  85. Review: Does Gabapentin Relieve Opioids, Cannabis and Methamphetamines Addictions?
    Gabriel C. Quintero Garzola · 2020 · Revista Colombiana de Psicología
  86. Cannabis Use Disorder and Its Treatment
    Alan Jeffrey Budney, Michael J. Sofis · 2020 · Springer eBooks
  87. Chapter 17. Treatment of Cannabis-Related Disorders
    Christina Brezing, Souparno Mitra, FRANCES RUDNICK LEVIN · 2021 · American Psychiatric Association Publishing eBooks
  88. Treatment of Regular Heavy Marijuana Users
    Timmen L. Cermak · 2020 · Cambridge University Press eBooks
  89. Is your patient’s cannabis use problematic?
    Michael Hsu · 2020 · The Journal of Family Practice
  90. The Science and Art of Healing
    Timmen L. Cermak · 2020
  91. Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkankungen, 9. Auflage
    2013 · Elsevier eBooks
  92. References
    Brian S. Fulton · 2014 · Wiley eBooks
  93. Pharmacotherapy for Substance Use Disorders
    2019 · American Psychiatric Association Publishing eBooks
  94. Mood Stabilizers
    2019 · American Psychiatric Association Publishing eBooks
  95. Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 13. Auflage
    2017 · Elsevier eBooks
  96. Mood Stabilizers
    2019 · American Psychiatric Association Publishing eBooks
  97. Pharmacotherapy for Substance Use Disorders
    2019 · American Psychiatric Association Publishing eBooks
  98. Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 14. Auflage
    2019 · Elsevier eBooks
  99. Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 10. Auflage
    2014 · Elsevier eBooks
  100. DESAFIOS DA SEGURANÇA DO PACIENTE NO AMBIENTE HOSPITALAR PSIQUIÁTRICO
    Francinéa Rodrigues de Lima · 2022 · Amplla Editora eBooks